NEOTEC
Development of a new in vitro test based on nuclear magnetic resonance spectroscopy for the early detection of cardiometabolic and cardiovascular disease.
- Biosfer Teslab’s role
- Beneficiary company
- Related fields
Development of a new in vitro test based on nuclear magnetic resonance spectroscopy for the early detection of cardiometabolic and cardiovascular disease.